0.9% w/v sodium chloride solution

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	3

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01181622 (ClinicalTrials.gov)	August 2010	12/8/2010	A Safety and Tolerability Study of Denufosol in 2-4 Year Olds	A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 7-Day Safety ...	Cystic Fibrosis	Drug: denufosol tetrasodium Inhalation Solution;Drug: 0.9% w/v sodium chloride solution	Merck Sharp & Dohme Corp.	NULL	Completed	2 Years	4 Years	Both	25	Phase 2	United States
2	NCT00357279 (ClinicalTrials.gov)	July 2006	25/7/2006	Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease	A Multi-Center, Double-Blind, Placebo-Controlled Randomized, Efficacy and Safety Study of Denufosol ...	Cystic Fibrosis	Drug: denufosol tetrasodium (INS37217) Inhalation Solution;Drug: Placebo - 0.9% w/v sodium chloride ...	Merck Sharp & Dohme Corp.	NULL	Completed	5 Years	N/A	Both	352	Phase 3	United States;Canada
3	EUCTR2015-004143-39-FR (EUCTR)		30/03/2017	Saline hypertonic in preschoolers and lung structure as measured by computed tomography.	A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9%isot ...	Cystic Fibrosis MedDRA version: 20.0;Level: PT;Classification code 10011763;Term: Cystic fibrosis lu ...	Product Name: Hypertonic saline 7% INN or Proposed INN: SODIUM CHLORIDE Other descriptive name: SODIUM ...	Erasmus MC	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 3	United States;France;Spain;Belgium;Denmark;Australia;Netherlands;Italy

First Previous1Next Last